Gp-act Iii Acquisition CORP

GP-Act III Acquisition Corp. is seeking shareholder approval to extend its deadline for completing a business combination from May 13, 2026, to November 13, 2026, through non-redemption agreements.

GP-Act III Acquisition Corp. has adjourned its extraordinary general meeting to May 12, 2026, to allow further solicitation of votes on proposals to extend the deadline for a business combination and trust account liquidation.

GP-Act III Acquisition Corp. will allow separate trading of its Class A ordinary shares and redeemable warrants starting July 1, 2024.

GP-Act III Acquisition Corp. successfully completed its initial public offering, raising $287.5 million through the sale of units and private placement warrants.

GP-Act III Acquisition Corp. successfully closed its initial public offering, raising $287.5 million to pursue a business combination, primarily in the United States.

GP-Act III Acquisition Corp. reports Q1 2026 financial results, with net income of $2.15 million, and shareholders approve extension of business combination deadline to November 13, 2026.

GP-Act III Acquisition Corp. reports Q3 2025 net income of $3.1 million, but faces substantial doubt about its ability to continue as a going concern without a business combination by May 2026.

GP-Act III Acquisition Corp. reports increased net income driven by trust account interest, but faces a looming May 2026 business combination deadline and a going concern warning.

GP-Act III Acquisition Corp. reports a net income of $2.9 million for the quarter ended March 31, 2025, primarily due to interest earned on marketable securities held in its Trust Account.

GP-Act III Acquisition Corp. reported a net income of $3.66 million for the third quarter of 2024, primarily driven by interest earned on marketable securities held in trust.

GP-Act III Acquisition Corp. reported a net income of $1.7 million for the second quarter of 2024, primarily driven by interest earned on its trust account after its initial public offering.

GP-Act III Acquisition Corp., a blank check company, filed its 2025 Annual Report on Form 10-K, detailing its financial position, ongoing search for a business combination, and associated risks.

GP-Act III Acquisition Corp. files its annual report on Form 10-K, outlining its IPO, ongoing search for a business combination target, and associated risks.

GP-Act III calls an April 29, 2026 vote to extend its merger deadline to November 13, 2026 and align its trust agreement, while offering redemptions at about $10.84 per share.

GP-Act III Acquisition Corp. files an amendment to its Form S-1 registration statement, clarifying the execution date of an opinion from Maples and Calder (Cayman) LLP.

GP-Act III Acquisition Corp. has filed an amendment to its S-1 registration statement, primarily related to exhibits and certain administrative updates.

GP-Act III Acquisition Corp., a blank check company, files for a $250 million IPO to target high-potential businesses in the United States.

Karpus Management, Inc. reports 0% beneficial ownership in GP-Act III Acquisition Corp., indicating a full divestment of its previously held stake.

Polar Asset Management Partners Inc. has filed a Schedule 13G reporting an 11.1% beneficial ownership stake in GP-Act III Acquisition Corp.

Picton Mahoney Asset Management has filed a Schedule 13G, reporting beneficial ownership of 4.78% of GP-ACT III Acquisition Corp's Class A Ordinary Shares.

Bank of Montreal and its affiliates have reported a complete divestment of their beneficial ownership in GP-Act III Acquisition Corp., now holding 0% of common shares.

Bank of Montreal and its affiliates have disclosed a combined beneficial ownership of 5.14% in GP-Act III Acquisition Corp.'s common stock.

Karpus Management, Inc. has filed an amended Schedule 13G, reporting a 6.51% beneficial ownership stake in GP-Act III Acquisition Corp. as of June 30, 2025.